Risk for systemic embolization of atrial fibrillation without mitral stenosis

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Atrial fibrillation (AF) is a common arrhythmia associated with an increased risk of systemic embolization.
• Predicting embolic events in AF patients without mitral stenosis or prosthetic valves is crucial for guiding treatment.
• Echocardiography plays a key role in assessing cardiac structures and function relevant to embolic risk.

Purpose of the Study:

• To identify predictors of systemic embolization in patients with atrial fibrillation (AF) but without mitral stenosis or prosthetic valves.
• To develop a risk stratification tool for predicting embolic events in this specific patient population.
• To inform clinical decision-making regarding anticoagulation therapy in AF patients.

Main Methods:

• Retrospective analysis of 272 patients with AF referred for echocardiography.
• Systemic embolic events (cerebral and peripheral) were tracked during a mean follow-up of 33 months.
• Multivariable analysis was used to identify independent predictors of embolization, and a risk score was developed.

Main Results:

• 27% of patients experienced a systemic embolic event, predominantly cerebral (85%).
• Left atrial size (≥4.0 cm), female sex, and underlying heart disease were significant predictors of embolization.
• A risk score based on these factors effectively stratified patients into low-, medium-, and high-risk groups for embolic events.

Conclusions:

• Left atrial size, female sex, and underlying heart disease are key predictors of systemic embolization risk in AF patients without mitral stenosis or prosthetic valves.
• A simple risk score can stratify these patients, aiding in personalized anticoagulation strategies.
• This risk stratification may improve the management and prevention of embolic complications in AF.